Journey Medical Corp. (DERM)
7.40
-0.13
(-1.73%)
USD |
NASDAQ |
Aug 28, 13:01
Journey Medical Cash from Operations (Quarterly) : -1.734M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.734M |
| March 31, 2026 | 2.909M |
| December 31, 2025 | -6.359M |
| September 30, 2025 | -2.383M |
| June 30, 2025 | -0.942M |
| March 31, 2025 | -2.832M |
| December 31, 2024 | 2.225M |
| September 30, 2024 | -1.157M |
| June 30, 2024 | -5.176M |
| March 31, 2024 | -5.019M |
| December 31, 2023 | -16.43M |
| September 30, 2023 | 18.75M |
| Date | Value |
|---|---|
| June 30, 2023 | 3.878M |
| March 31, 2023 | -0.956M |
| December 31, 2022 | -3.836M |
| September 30, 2022 | -7.282M |
| June 30, 2022 | -3.30M |
| March 31, 2022 | 0.884M |
| December 31, 2021 | -3.206M |
| September 30, 2021 | 7.102M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 5.054M |
| September 30, 2020 | -1.071M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Nektar Therapeutics | -75.77M |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Veru, Inc. | -5.467M |
| Johnson & Johnson | 8.616B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.158M |
| Free Cash Flow | -7.567M |
| Free Cash Flow Per Share (Quarterly) | -0.0631 |
| Free Cash Flow to Equity (Quarterly) | -1.808M |
| Free Cash Flow to Firm (Quarterly) | -0.7822M |
| Free Cash Flow Yield | -3.83% |